Free Newsletter
Sanofi said to drop out of Ratiopharm race
Free newsletter via e-mail
Tools
Sanofi-Aventis dropped its bid for the German generics maker Ratiopharm in favor of deals for companies bringing new products to the table or offering access to new markets, Bloomberg reports. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: